According to
Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare plan stocks to buy right now are:
1. Oscar Health (NYSE:OSCR)
Oscar Health (NYSE:OSCR) is the #1 top healthcare plan stock out of 10 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year.
Learn more.
The Component Grade breakdown for Oscar Health (NYSE:OSCR) is: Value: A, Growth: B, Momentum: A, Sentiment: A, Safety: C, Financials: B, and AI: C.
Oscar Health (NYSE:OSCR) has a Due Diligence Score of 54, which is 13 points higher than the healthcare plan industry average of 41.
OSCR passed 18 out of 33 due diligence checks and has strong fundamentals. Oscar Health has seen its stock return 111.52% over the past year, overperforming other healthcare plan stocks by 76 percentage points.
Oscar Health has an average 1 year
price target of $37.00, an upside of 15.84% from Oscar Health's current stock price of $31.94.
Oscar Health stock has a consensus Buy recommendation according to Wall Street analysts. Of the 8 analysts covering Oscar Health, 25% have issued a Strong Buy rating, 12.5% have issued a Buy, 50% have issued a hold, while 12.5% have issued a Sell rating, and 0% have issued a Strong Sell.
2. Clover Health Investments (NASDAQ:CLOV)
The Component Grade breakdown for Clover Health Investments (NASDAQ:CLOV) is: Value: C, Growth: A, Momentum: A, Sentiment: A, Safety: C, Financials: C, and AI: C.
Clover Health Investments (NASDAQ:CLOV) has a Due Diligence Score of 54, which is 13 points higher than the healthcare plan industry average of 41.
CLOV passed 18 out of 33 due diligence checks and has strong fundamentals. Clover Health Investments has seen its stock return 94.42% over the past year, overperforming other healthcare plan stocks by 59 percentage points.
Clover Health Investments has an average 1 year
price target of $5.67, an upside of 16.13% from Clover Health Investments's current stock price of $4.88.
Clover Health Investments stock has a consensus Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Clover Health Investments, 33.33% have issued a Strong Buy rating, 33.33% have issued a Buy, 33.33% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.
3. Unitedhealth Group (NYSE:UNH)
The Component Grade breakdown for Unitedhealth Group (NYSE:UNH) is: Value: C, Growth: C, Momentum: B, Sentiment: B, Safety: C, Financials: C, and AI: B.
Unitedhealth Group (NYSE:UNH) has a Due Diligence Score of 35, which is -6 points lower than the healthcare plan industry average of 41. Although this number is below the industry average, our proven quant model rates UNH as a "B".
UNH passed 12 out of 38 due diligence checks and has average fundamentals. Unitedhealth Group has seen its stock return 19.49% over the past year, underperforming other healthcare plan stocks by -16 percentage points.
Unitedhealth Group has an average 1 year
price target of $477.65, an upside of 17.9% from Unitedhealth Group's current stock price of $405.13.
Unitedhealth Group stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 17 analysts covering Unitedhealth Group, 52.94% have issued a Strong Buy rating, 29.41% have issued a Buy, 17.65% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.